Updated on 5/4/2020
Three IPOs and one SPAC are scheduled for the week ahead.
Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
Galera Therapeutics, a Phase 3 biotech developing treatments for radiotherapy-induced oral mucositis, raised $60 million by offering 5.0 million shares at $12, below the range of $14 to $16. Insiders had indicated on buying up to $40 million of the...read more
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more
US IPO Week Ahead: GAN bets on itself in a 3 IPO week
Updated on 5/4/2020 Three IPOs and one SPAC are scheduled for the week ahead. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
US IPO Weekly Recap: Small Chinese and healthcare deals price down in an 8-IPO week
Eight small companies and four SPACs entered the public market this past week. Continuing a 4Q trend, all eight deals...read more
Mucositis biotech Galera Therapeutics prices IPO below the range at $12
Galera Therapeutics, a Phase 3 biotech developing treatments for radiotherapy-induced oral mucositis, raised $60 million by offering 5.0 million shares at $12, below the range of $14 to $16. Insiders had indicated on buying up to $40 million of the...read more
US IPO Week Ahead: The largest Canadian IPO ever leads a 9-IPO week
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more